- Total income
- ₹7,234 Cr
- Profit
- ₹331 Cr

Aarti Industries
About Aarti Industries
Aarti Industries is a publicly listed company based in Mumbai (India) founded in 1984 by Chandrakant Gogri. Specialty chemicals, pharmaceuticals, and surfactants are manufactured. The company has 13,910 employees. Its chief executive, as recorded, is Suyog Kotecha. Its website aarti-industries.com draws about 16 thousand monthly visits. Its Indian entity Aarti Industries Ltd reported revenue of βΉ8,319 Cr. Aarti Industries offers products and services including Para Dichloro Benzene, Nitro Benzene, Ortho Nitro Chloro Benzene, 2,4 Dinitro Chloro Benzene, and Hydro Chloric Acid. Its focus areas include Chemicals and Materials, Diversified Chemicals and Speciality Chemicals.
Company details
Founded in 1984 and based in Mumbai, India, operations are centered on the production of specialty chemicals, pharmaceutical intermediates, and surfactants. The pharmaceutical division handles API intermediates, custom synthesis, contract research, and facilities for steroids and oncology drugs. Surfactants serve personal care, industrial, agro, and home care sectors. Chemicals produced support APIs, agrochemicals, polymers, additives, pigments, and dyes.
Aarti Industries is ranked #342 on the Fortune India 500 (2025) and #299 among India's most valuable companies (2025).
Recognitions & Rankings of Aarti Industries
- Valuation
- ₹18,410 Cr
- Headquarters Mumbai, India
- Employees 13,910
- Founders Chandrakant Gogri
- Stage Public
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website aarti-industries.com
- Social LinkedIn X
- Legal Name Aarti Industries Ltd
- Market Cap₹16,008 Cr
AARTIIND · NSE
- Share Price₹427.55
-3.12% today
- Revenue₹8,286 Cr
FY 2025-26 · +14.0% YoY
- EBITDA₹1,146 Cr
Margin 13.8%
- Net Profit₹412 Cr
FY 2025-26 · +25.8% YoY
- P/E (TTM)32.3x
P/B 2.8x
- ROE7.2%
ROCE 6.8%
- Debt / Equity0.76
Interest cover 50.6x
- Employee Count13,910
Associated legal entities of Aarti Industries
Aarti Industries is associated with 8 registered companies on The Company Check; the primary company is Aarti Industries Ltd, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aarti Industries Ltd Listed CIN L24110GJ1984PLC007301 | Active | 28 Sep 1984 | Vapi, Gujarat | ₹8,319 Cr | 5,563 | 19 | View details |
| Aarti Pharmalabs Limited Listed CIN L24100GJ2019PLC110964 | Active | 22 Nov 2019 | Vapi, Gujarat | ₹1,837 Cr | 2,004 | 14 | View details |
| Gogri Ventures Llp CIN AAO-3384 | Active | 20 Feb 2019 | Mumbai, Maharashtra | 2 | View details | ||
| Rcg Ventures Llp CIN AAO-3388 | Active | 20 Feb 2019 | Mumbai, Maharashtra | 2 | View details | ||
| Het Ventures Llp CIN AAO-2556 | Active | 12 Feb 2019 | Mumbai, Maharashtra | 2 | View details | ||
| Dhanvallabh Enterprises Llp CIN AAO-1912 | Active | 01 Feb 2019 | Mumbai, Maharashtra | 2 | View details | ||
| Alchemie Speciality Chemicals Private Limited CIN U24299MH2016PTC284777 | Active | 12 Aug 2016 | Mumbai, Maharashtra, India | View details | |||
| Indace Chem India Private Limited CIN U24100MH2008PTC188049 | Active | 07 Nov 2008 | Thane, Maharashtra, India | View details |
Products & Services of Aarti Industries
Aarti Industries offers a comprehensive portfolio of products and services, including Para Dichloro Benzene, Nitro Benzene, Ortho Nitro Chloro Benzene, 2,4 Dinitro Chloro Benzene, and Hydro Chloric Acid.
Used in manufacturing of downstream chemical products
Key ingredient for dyes and agrochemicals
Applied in pigments and pharmaceutical synthesis
Utilized in dye production and intermediates
Essential for industrial processes and acid applications
Funding Insights of Aarti Industries
- Total Rounds 3
- First Round $10.57M
(Jun 2019)
All 3 funding rounds of Aarti Industries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | Post-IPO | β | β | β | |
| May 2021 | Post-IPO | β | β | β | |
| Jun 2019 | $10.57M | Post-IPO | β | β | β |
Board of directors of Aarti Industries Ltd (Aarti Industries)
Aarti Industries Ltd is the primary company behind Aarti Industries. The boards of the 6 registered companies of Aarti Industries currently have 28 directors; the longest-serving is Manoj Mulji Chheda, appointed in 1993. 38 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manoj Mulji Chheda DIN 00022699 | Whole-time director | 25 Nov 1993 | 32 yrs 10 mo | Aarti Industries Ltd |
| Renil Rajendra Gogri DIN 01582147 | Whole-time director | 16 Aug 2012 | 14 yrs 2 mo | Aarti Industries Ltd |
| Rajendra Vallabhaji Gogri DIN 00061003 | Managing Director | 01 Jul 2013 | 13 yrs 3 mo | Aarti Industries Ltd, Aarti Pharmalabs Limited |
| Chetan Bipin Gandhi DIN 06843850 | CFO | 30 May 2014 | 12 yrs 4 mo | Aarti Industries Ltd |
| Raj Kumar Sarraf DIN 07917766 | Company Secretary | 16 Nov 2017 | 8 yrs 11 mo | Aarti Industries Ltd |
| Manisha Rashesh Gogri DIN 01478878 | Designated Partner | 01 Feb 2019 | 7 yrs 8 mo | Dhanvallabh Enterprises Llp |
| Hetal Gogri Gala DIN 00005499 | Designated Partner | 20 Feb 2019 | 7 yrs 8 mo | Gogri Ventures Llp, Rcg Ventures Llp, Aarti Industries Ltd, Aarti Pharmalabs Limited |
| Rashesh Chandrakant Gogri DIN 00066291 | Designated Partner | 20 Feb 2019 | 7 yrs 8 mo | Gogri Ventures Llp, Rcg Ventures Llp, Dhanvallabh Enterprises Llp, Aarti Industries Ltd, Aarti Pharmalabs Limited |
| Lalitkumar Shantaram Naik DIN 02943588 | Director | 21 May 2019 | 7 yrs 5 mo | Aarti Industries Ltd |
| Narendra Jagannath Salvi DIN 00299202 | Managing Director | 07 Aug 2021 | 5 yrs 2 mo | Aarti Pharmalabs Limited |
| Chandrakant Vallabhaji Gogri DIN 00005048 | Designated Partner | 27 Sep 2022 | 4 yrs | Het Ventures Llp |
| Jaya Chandrakant Gogri DIN 01373297 | Designated Partner | 27 Sep 2022 | 4 yrs | Het Ventures Llp |
| Vilas Gaikar Gajanan DIN 00033383 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Rupal Anand Vora DIN 07096253 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Parimal Hasmukhlal Desai DIN 00009272 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Bhavesh Rasiklal Vora DIN 00267604 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Vinay Gopal Nayak DIN 02577389 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Jeenal Kenil Savla DIN 07545244 | Director | 17 Oct 2022 | 4 yrs | Aarti Pharmalabs Limited |
| Shekhar Shreedhar Khanolkar DIN 02202839 | Director | 29 Jun 2023 | 3 yrs 3 mo | Aarti Industries Ltd |
| Ajay Kumar Gupta DIN 08619902 | Director | 29 Jun 2023 | 3 yrs 3 mo | Aarti Industries Ltd |
| Anniruddha Bhalchandra Pandit DIN 02471158 | Director | 29 Jun 2023 | 3 yrs 3 mo | Aarti Industries Ltd |
| Pradeep Hari Thakur DIN 00685992 | Director | 13 May 2024 | 2 yrs 5 mo | Aarti Pharmalabs Limited |
| Nehal Garewal DIN 01750146 | Director | 13 May 2024 | 2 yrs 5 mo | Aarti Pharmalabs Limited |
| Belur Krishna Murthy Sethuram DIN 03498701 | Director | 01 Jun 2024 | 2 yrs 4 mo | Aarti Industries Ltd |
| Suyog Kalyanji Kotecha DIN 10634964 | Director | 17 Jun 2024 | 2 yrs 4 mo | Aarti Industries Ltd |
| Ashok Kumar Barat DIN 00492930 | Director | 15 Sep 2024 | 2 yrs 1 mo | Aarti Industries Ltd |
| Nikhil Jaysinh Bhatia DIN 00414281 | Director | 15 Sep 2024 | 2 yrs 1 mo | Aarti Industries Ltd |
| Rupa Devi Singh DIN 02191943 | Director | 15 Sep 2024 | 2 yrs 1 mo | Aarti Industries Ltd |
People of Aarti Industries
2 people are tracked at Aarti Industries (2 in leadership); the tracked headcount is 13,910.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
| CEO | Leadership |
Complete people profiles for Aarti Industries
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Aarti Industries
Aarti Industries is a publicly listed company on the NSE with ticker symbol AARTIIND in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jan 2006
- Listed onBSE: 524208
- Listed entityAARTI Industries Ltd
- Exchange sectorProcess industries
- ISININE769A01020
- Share price₹497.90 (+2.07% on the day) · 2026-10-14
- Market capitalisation₹17,680 Cr
- Price to earnings34.1
- EPS (diluted, trailing year)₹14.62
- Dividend yield0.21%
- Volume (last session)697,904
Financials of Aarti Industries
Exchange-reported figures of Aarti Industries Ltd, the listed company behind Aarti Industries (NSE: AARTIIND).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 8,286 | 7,269 | 6,371 | 6,619 | 6,086 | 4,506 | 4,186 |
| Revenue growth | +14.0% | +14.1% | -3.7% | +8.8% | +35.1% | +7.6% | - |
| EBITDA | 1,146 | 997 | 974 | 1,089 | 1,720 | 982 | 977 |
| EBITDA margin | +13.8% | +13.7% | +15.3% | +16.5% | +28.3% | +21.8% | +23.4% |
| Profit before tax | 365 | 307 | 395 | 611 | 1,372 | 665 | 676 |
| Net profit | 412 | 328 | 420 | 545 | 1,185 | 523 | 529 |
| Net profit margin | +5.0% | +4.5% | +6.6% | +8.2% | +19.5% | +11.6% | +12.6% |
| EPS (βΉ) | 11.56 | 9.13 | 11.49 | 15.04 | 32.71 | 30.04 | 30.77 |
| Balance sheet | |||||||
| Total assets | 11,006 | 9,580 | 9,102 | 8,045 | 7,327 | 6,583 | 5,722 |
| Net worth | 5,955 | 5,605 | 5,290 | 4,920 | 4,516 | 3,503 | 2,979 |
| Total debt | 4,966 | 3,848 | 3,623 | 2,907 | 2,587 | 2,857 | 2,098 |
| Cash & bank | 608 | 295 | 516 | 201 | 174 | 412 | 247 |
| Net working capital | 1,893 | 1,362 | 1,946 | 1,923 | 2,175 | 1,543 | 1,606 |
| Cash flow | |||||||
| Cash from operations | 781 | 1,238 | 1,210 | 1,319 | 519 | 873 | 1,102 |
| Cash from investing | (1,142) | (1,393) | (1,369) | (1,330) | (1,169) | (1,322) | (1,124) |
| Cash from financing | 745 | (73.17) | 420 | 38.21 | 412 | 614 | (535) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,387 | 2,205 | 2,318 | 2,100 | 1,675 | 1,949 | 1,843 | 1,628 |
| Revenue growth (YoY) | +42.5% | +13.1% | +25.8% | +29.0% | -9.5% | - | - | - |
| Other income | 5.00 | 1.00 | 2.00 | 22.00 | 4.00 | 3.00 | 5.00 | 7.00 |
| EBITDA | 382 | 341 | 306 | 291 | 212 | 262 | 231 | 197 |
| EBITDA margin | +16.0% | +15.5% | +13.2% | +13.9% | +12.7% | +13.4% | +12.5% | +12.1% |
| Depreciation | 124 | 119 | 121 | 120 | 114 | 113 | 111 | 108 |
| Interest | 83.00 | 112 | 69.00 | 100 | 60.00 | 64.00 | 85.00 | 62.00 |
| Profit before tax | 180 | 111 | 118 | 93.00 | 42.00 | 88.00 | 40.00 | 34.00 |
| Tax | 25.00 | (26.00) | (15.00) | (13.00) | (1.00) | (8.00) | (6.00) | (18.00) |
| Net profit | 155 | 137 | 133 | 106 | 43.00 | 96.00 | 46.00 | 52.00 |
| EPS (βΉ) | 4.26 | 3.78 | 3.66 | 2.91 | 1.19 | 2.64 | 1.27 | 1.44 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 8,422 | 7,302 | 6,346 | 6,565 | 6,040 | 4,317 | 3,994 |
| Revenue growth | +15.3% | +15.1% | -3.3% | +8.7% | +39.9% | +8.1% | - |
| EBITDA | 1,141 | 1,002 | 974 | 1,088 | 1,711 | 935 | 930 |
| EBITDA margin | +13.5% | +13.7% | +15.3% | +16.6% | +28.3% | +21.7% | +23.3% |
| Profit before tax | 365 | 316 | 396 | 613 | 1,366 | 632 | 646 |
| Net profit | 415 | 339 | 421 | 546 | 1,182 | 513 | 517 |
| Net profit margin | +4.9% | +4.7% | +6.6% | +8.3% | +19.6% | +11.9% | +12.9% |
| EPS (βΉ) | 11.65 | 9.37 | 11.51 | 15.06 | 32.61 | 29.47 | 30.04 |
| Balance sheet | |||||||
| Total assets | 11,021 | 9,592 | 9,103 | 8,045 | 7,306 | 6,474 | 5,525 |
| Net worth | 5,972 | 5,618 | 5,292 | 4,921 | 4,501 | 3,412 | 2,902 |
| Total debt | 4,965 | 3,846 | 3,622 | 2,907 | 2,581 | 2,851 | 2,073 |
| Cash & bank | 436 | 293 | 512 | 194 | 167 | 406 | 233 |
| Net working capital | 1,900 | 1,372 | 1,946 | 1,930 | 2,181 | 1,523 | 1,566 |
| Cash flow | |||||||
| Cash from operations | 608 | 1,229 | 1,159 | 1,272 | 507 | 844 | 1,065 |
| Cash from investing | (1,141) | (1,382) | (1,317) | (1,301) | (1,162) | (1,307) | (1,109) |
| Cash from financing | 746 | (73.52) | 421 | 55.28 | 417 | 635 | (520) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,241 | 2,439 | 2,276 | 2,084 | 1,636 | 1,992 | 1,749 | 1,717 |
| Revenue growth (YoY) | +37.0% | +22.4% | +30.1% | +21.4% | -11.3% | - | - | - |
| Other income | 3.00 | 0.00 | 2.00 | 23.00 | 4.00 | 4.00 | 6.00 | 8.00 |
| Total expenses | 1,875 | 2,090 | 1,973 | 1,800 | 1,424 | 1,727 | 1,519 | 1,518 |
| EBITDA | 366 | 349 | 303 | 284 | 212 | 265 | 230 | 199 |
| EBITDA margin | +16.3% | +14.3% | +13.3% | +13.6% | +13.0% | +13.3% | +13.2% | +11.6% |
| Depreciation | 124 | 118 | 121 | 120 | 114 | 113 | 110 | 108 |
| Interest | 82.00 | 112 | 68.00 | 98.00 | 60.00 | 64.00 | 85.00 | 62.00 |
| Profit before tax | 163 | 119 | 116 | 89.00 | 42.00 | 92.00 | 41.00 | 37.00 |
| Tax | 19.00 | (28.00) | (15.00) | (13.00) | (2.00) | (7.00) | (6.00) | (18.00) |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,387 | 2,205 | 2,318 | 2,100 | 1,675 | 1,949 | 1,843 | 1,628 |
| Revenue growth (YoY) | +42.5% | +13.1% | +25.8% | +29.0% | -9.5% | - | - | - |
| Other income | 5.00 | 1.00 | 2.00 | 22.00 | 4.00 | 3.00 | 5.00 | 7.00 |
| EBITDA | 382 | 341 | 306 | 291 | 212 | 262 | 231 | 197 |
| EBITDA margin | +16.0% | +15.5% | +13.2% | +13.9% | +12.7% | +13.4% | +12.5% | +12.1% |
| Depreciation | 124 | 119 | 121 | 120 | 114 | 113 | 111 | 108 |
| Interest | 83.00 | 112 | 69.00 | 100 | 60.00 | 64.00 | 85.00 | 62.00 |
| Profit before tax | 180 | 111 | 118 | 93.00 | 42.00 | 88.00 | 40.00 | 34.00 |
| Tax | 25.00 | (26.00) | (15.00) | (13.00) | (1.00) | (8.00) | (6.00) | (18.00) |
| Net profit | 155 | 137 | 133 | 106 | 43.00 | 96.00 | 46.00 | 52.00 |
| EPS (βΉ) | 4.26 | 3.78 | 3.66 | 2.91 | 1.19 | 2.64 | 1.27 | 1.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 8,286 | 7,269 | 6,371 | 6,619 | 6,086 | 4,506 | 4,186 |
| Revenue growth | +14.0% | +14.1% | -3.7% | +8.8% | +35.1% | +7.6% | - |
| Other income | 33.38 | 19.89 | 10.86 | 0.86 | 0.77 | 0.70 | 8.84 |
| Total expenses | 7,141 | 6,272 | 5,397 | 5,530 | 4,365 | 3,525 | 3,209 |
| Employee cost | 422 | 447 | 404 | 385 | 357 | 371 | 305 |
| EBITDA | 1,146 | 997 | 974 | 1,089 | 1,720 | 982 | 977 |
| EBITDA margin | +13.8% | +13.7% | +15.3% | +16.5% | +28.3% | +21.8% | +23.4% |
| Depreciation | 474 | 434 | 378 | 310 | 246 | 231 | 185 |
| Interest | 340 | 275 | 211 | 168 | 102 | 86.37 | 125 |
| Profit before tax | 365 | 307 | 395 | 611 | 1,372 | 665 | 676 |
| Tax | (54.34) | (23.63) | (21.05) | 65.87 | 186 | 129 | 129 |
| Net profit | 412 | 328 | 420 | 545 | 1,185 | 523 | 529 |
| Net profit margin | +5.0% | +4.5% | +6.6% | +8.2% | +19.5% | +11.6% | +12.6% |
| EPS (βΉ) | 11.56 | 9.13 | 11.49 | 15.04 | 32.71 | 30.04 | 30.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 181 | 181 | 181 | 181 | 181 | 87.12 | 87.12 |
| Reserves & surplus | 5,774 | 5,424 | 5,109 | 4,739 | 4,335 | 3,416 | 2,892 |
| Shareholders' funds (net worth) | 5,955 | 5,605 | 5,290 | 4,920 | 4,516 | 3,503 | 2,979 |
| Minority interest | 0.10 | 0.10 | 0.72 | 0.72 | 0.72 | 12.24 | 94.62 |
| Secured loans | 3,920 | 3,738 | 3,513 | 2,471 | 2,517 | 2,766 | 2,073 |
| Unsecured loans | 1,046 | 110 | 109 | 437 | 69.87 | 90.68 | 24.60 |
| Total debt | 4,966 | 3,848 | 3,623 | 2,907 | 2,587 | 2,857 | 2,098 |
| Total liabilities | 11,006 | 9,580 | 9,102 | 8,045 | 7,327 | 6,583 | 5,722 |
| Assets | |||||||
| Gross block | 8,932 | 8,428 | 7,291 | 6,306 | 5,048 | 5,155 | 3,837 |
| Net block | 6,399 | 6,377 | 5,649 | 4,861 | 3,595 | 3,593 | 2,468 |
| Capital work in progress | 2,187 | 1,454 | 1,229 | 1,096 | 1,346 | 1,298 | 1,418 |
| Investments | 132 | 47.63 | 22.92 | 17.17 | 28.29 | 63.52 | 37.01 |
| Inventories | 1,732 | 1,454 | 1,160 | 1,031 | 934 | 936 | 836 |
| Sundry debtors | 1,403 | 786 | 854 | 940 | 1,092 | 794 | 753 |
| Cash & bank balances | 608 | 295 | 516 | 201 | 174 | 412 | 247 |
| Loans & advances | 444 | 360 | 429 | 287 | 500 | 226 | 168 |
| Total current assets | 4,187 | 2,895 | 2,959 | 2,459 | 2,699 | 2,368 | 2,005 |
| Total current liabilities | 2,295 | 1,533 | 1,013 | 536 | 523 | 824 | 399 |
| Net working capital | 1,893 | 1,362 | 1,946 | 1,923 | 2,175 | 1,543 | 1,606 |
| Total assets | 11,006 | 9,580 | 9,102 | 8,045 | 7,327 | 6,583 | 5,722 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 199 | 428 | 167 | 174 | 412 | 247 | 804 |
| Net cash from operating activities | 781 | 1,238 | 1,210 | 1,319 | 519 | 873 | 1,102 |
| Net cash from investing activities | (1,142) | (1,393) | (1,369) | (1,330) | (1,169) | (1,322) | (1,124) |
| Net cash from financing activities | 745 | (73.17) | 420 | 38.21 | 412 | 614 | (535) |
| Net change in cash | 383 | (229) | 261 | 27.17 | (239) | 165 | (557) |
| Closing cash | 608 | 295 | 516 | 201 | 174 | 412 | 247 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +14.0% | +14.1% | -3.7% | +8.8% | +35.1% | +7.6% | - |
| EBITDA growth | +14.9% | +2.4% | -10.5% | -36.7% | +75.3% | +0.4% | - |
| PBT growth | +18.7% | -22.3% | -35.3% | -55.5% | +106.5% | -1.7% | +8.7% |
| Net income growth | +25.8% | -21.9% | -23.0% | -54.0% | +126.5% | -1.2% | - |
| Revenue CAGR (3Y) | +7.8% | +6.1% | +12.2% | +16.5% | +13.5% | +5.8% | +9.8% |
| EBITDA CAGR (3Y) | +1.7% | -16.6% | -0.3% | +3.7% | +21.2% | +12.0% | +14.4% |
| Profitability & leverage | |||||||
| Net income margin | +5.1% | +4.6% | +6.5% | +8.2% | +19.5% | +11.9% | +13.1% |
| Return on capital employed | +6.9% | +6.2% | +7.1% | +10.1% | +21.2% | +12.3% | +14.8% |
| Return on net worth | +7.3% | +6.1% | +8.2% | +11.6% | +29.6% | +16.5% | +19.5% |
| Debt / equity | 0.76 | 0.69 | 0.64 | 0.58 | 0.68 | 0.76 | 0.80 |
| Long-term debt / equity | 0.36 | 0.32 | 0.22 | 0.17 | 0.28 | 0.29 | 0.25 |
| Interest cover | 50.63 | 48.94 | 35.48 | 21.62 | 6.94 | 11.51 | 15.75 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.04 | 1.02 | 1.03 | 1.28 | 1.35 | 1.12 | 1.28 |
| Inventory turnover | 5.66 | 6.16 | 6.40 | 7.41 | 7.35 | 5.67 | 5.75 |
| Debtors turnover | 8.24 | 9.81 | 7.81 | 7.17 | 7.29 | 6.49 | 6.04 |
| EPS (βΉ) | 11.56 | 9.13 | 11.49 | 15.04 | 32.71 | 30.04 | 30.77 |
| Dividend per share (βΉ) | 1.00 | 1.00 | 1.00 | 2.50 | 3.50 | 3.00 | 3.50 |
| Book value per share (βΉ) | 164.24 | 154.62 | 145.92 | 135.73 | 124.58 | 201.01 | 170.93 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,241 | 2,439 | 2,276 | 2,084 | 1,636 | 1,992 | 1,749 | 1,717 |
| Revenue growth (YoY) | +37.0% | +22.4% | +30.1% | +21.4% | -11.3% | - | - | - |
| Other income | 3.00 | 0.00 | 2.00 | 23.00 | 4.00 | 4.00 | 6.00 | 8.00 |
| Total expenses | 1,875 | 2,090 | 1,973 | 1,800 | 1,424 | 1,727 | 1,519 | 1,518 |
| EBITDA | 366 | 349 | 303 | 284 | 212 | 265 | 230 | 199 |
| EBITDA margin | +16.3% | +14.3% | +13.3% | +13.6% | +13.0% | +13.3% | +13.2% | +11.6% |
| Depreciation | 124 | 118 | 121 | 120 | 114 | 113 | 110 | 108 |
| Interest | 82.00 | 112 | 68.00 | 98.00 | 60.00 | 64.00 | 85.00 | 62.00 |
| Profit before tax | 163 | 119 | 116 | 89.00 | 42.00 | 92.00 | 41.00 | 37.00 |
| Tax | 19.00 | (28.00) | (15.00) | (13.00) | (2.00) | (7.00) | (6.00) | (18.00) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 8,422 | 7,302 | 6,346 | 6,565 | 6,040 | 4,317 | 3,994 |
| Revenue growth | +15.3% | +15.1% | -3.3% | +8.7% | +39.9% | +8.1% | - |
| Other income | 36.39 | 22.65 | 10.85 | 0.42 | 0.69 | 1.95 | 10.51 |
| Total expenses | 7,282 | 6,300 | 5,372 | 5,477 | 4,329 | 3,382 | 3,065 |
| Employee cost | 420 | 445 | 402 | 383 | 354 | 358 | 292 |
| EBITDA | 1,141 | 1,002 | 974 | 1,088 | 1,711 | 935 | 930 |
| EBITDA margin | +13.5% | +13.7% | +15.3% | +16.6% | +28.3% | +21.7% | +23.3% |
| Depreciation | 473 | 433 | 377 | 310 | 244 | 218 | 173 |
| Interest | 339 | 275 | 211 | 166 | 102 | 86.16 | 122 |
| Profit before tax | 365 | 316 | 396 | 613 | 1,366 | 632 | 646 |
| Tax | (56.98) | (23.61) | (21.00) | 67.22 | 184 | 118 | 122 |
| Net profit | 415 | 339 | 421 | 546 | 1,182 | 513 | 517 |
| Net profit margin | +4.9% | +4.7% | +6.6% | +8.3% | +19.6% | +11.9% | +12.9% |
| EPS (βΉ) | 11.65 | 9.37 | 11.51 | 15.06 | 32.61 | 29.47 | 30.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 181 | 181 | 181 | 181 | 181 | 87.12 | 87.12 |
| Reserves & surplus | 5,791 | 5,437 | 5,111 | 4,740 | 4,320 | 3,325 | 2,815 |
| Shareholders' funds (net worth) | 5,972 | 5,618 | 5,292 | 4,921 | 4,501 | 3,412 | 2,902 |
| Secured loans | 3,920 | 3,738 | 3,513 | 2,471 | 2,513 | 2,762 | 2,049 |
| Unsecured loans | 1,045 | 109 | 108 | 437 | 68.24 | 89.21 | 23.20 |
| Total debt | 4,965 | 3,846 | 3,622 | 2,907 | 2,581 | 2,851 | 2,073 |
| Total liabilities | 11,021 | 9,592 | 9,103 | 8,045 | 7,306 | 6,474 | 5,525 |
| Assets | |||||||
| Gross block | 8,877 | 8,372 | 7,239 | 6,261 | 5,036 | 5,027 | 3,600 |
| Net block | 6,355 | 6,330 | 5,605 | 4,824 | 3,635 | 3,511 | 2,302 |
| Capital work in progress | 2,187 | 1,457 | 1,229 | 1,096 | 1,303 | 1,298 | 1,418 |
| Investments | 189 | 89.86 | 18.67 | 12.41 | 3.29 | 36.26 | 37.16 |
| Inventories | 1,297 | 1,388 | 1,151 | 1,015 | 899 | 901 | 781 |
| Sundry debtors | 1,864 | 857 | 895 | 974 | 1,131 | 819 | 782 |
| Cash & bank balances | 436 | 293 | 512 | 194 | 167 | 406 | 233 |
| Loans & advances | 442 | 358 | 428 | 292 | 509 | 225 | 144 |
| Total current assets | 4,038 | 2,896 | 2,986 | 2,475 | 2,706 | 2,351 | 1,941 |
| Total current liabilities | 2,138 | 1,524 | 1,039 | 545 | 524 | 829 | 375 |
| Net working capital | 1,900 | 1,372 | 1,946 | 1,930 | 2,181 | 1,523 | 1,566 |
| Total assets | 11,021 | 9,592 | 9,103 | 8,045 | 7,306 | 6,474 | 5,525 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 197 | 424 | 161 | 167 | 406 | 233 | 797 |
| Net cash from operating activities | 608 | 1,229 | 1,159 | 1,272 | 507 | 844 | 1,065 |
| Net cash from investing activities | (1,141) | (1,382) | (1,317) | (1,301) | (1,162) | (1,307) | (1,109) |
| Net cash from financing activities | 746 | (73.52) | 421 | 55.28 | 417 | 635 | (520) |
| Net change in cash | 213 | (227) | 263 | 26.96 | (239) | 173 | (564) |
| Closing cash | 436 | 293 | 512 | 194 | 167 | 406 | 233 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +15.3% | +15.1% | -3.3% | +8.7% | +39.9% | +8.1% | - |
| EBITDA growth | +13.9% | +2.9% | -10.6% | -36.4% | +83.1% | +0.5% | - |
| PBT growth | +15.6% | -20.3% | -35.3% | -55.1% | +116.1% | -2.2% | +9.3% |
| Net income growth | +22.4% | -19.3% | -22.9% | -53.8% | +130.2% | -0.7% | - |
| Revenue CAGR (3Y) | +8.7% | +6.5% | +13.7% | +18.0% | +14.5% | +5.3% | +9.4% |
| EBITDA CAGR (3Y) | +1.6% | -16.3% | +1.4% | +5.4% | +23.1% | +12.5% | +15.2% |
| Profitability & leverage | |||||||
| Net income margin | +5.0% | +4.7% | +6.6% | +8.3% | +19.6% | +11.9% | +13.1% |
| Return on capital employed | +6.8% | +6.3% | +7.1% | +10.2% | +21.3% | +12.0% | +14.4% |
| Return on net worth | +7.3% | +6.2% | +8.2% | +11.6% | +29.9% | +16.3% | +19.2% |
| Debt / equity | 0.76 | 0.68 | 0.64 | 0.58 | 0.69 | 0.78 | 0.81 |
| Long-term debt / equity | 0.36 | 0.32 | 0.22 | 0.17 | 0.28 | 0.29 | 0.25 |
| Interest cover | 50.73 | 48.40 | 35.34 | 21.30 | 6.92 | 12.03 | 16.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.06 | 1.03 | 1.03 | 1.28 | 1.36 | 1.11 | 1.31 |
| Inventory turnover | 6.82 | 6.36 | 6.45 | 7.55 | 7.58 | 5.71 | 5.95 |
| Debtors turnover | 6.73 | 9.22 | 7.47 | 6.87 | 6.99 | 6.00 | 5.55 |
| EPS (βΉ) | 11.65 | 9.37 | 11.51 | 15.06 | 32.61 | 29.47 | 30.04 |
| Dividend per share (βΉ) | 1.00 | 1.00 | 1.00 | 2.50 | 3.50 | 3.00 | 3.50 |
| Book value per share (βΉ) | 164.70 | 154.97 | 146.00 | 135.75 | 124.17 | 195.81 | 166.54 |
Timeline of Aarti Industries
4 dated milestones of Aarti Industries across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Aarti Industries is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $10.6M.
- Funding Latest funding round, Post-IPO,.
Web traffic of Aarti Industries
The website of Aarti Industries (aarti-industries.com) receives about 16.2K visits a month.
- Monthly visits16.2K
▼ 39.6% vs previous month
Websites whose visitors overlap most with Aarti Industries. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioplasticsnews.com | 100% | #1,760,069 | View details | ||
| dfpcl.com | 96% | 23.3K | #963,988 | View details | |
| indianchemicalcouncil.com | 96% | #6,435,962 | View details | ||
| chemarc.com | 96% | 3.6K | #5,098,307 | View details | |
| godeepak.com | 93% | 17K | #977,649 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Aarti Industries
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as Aarti Industries (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 2.13 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 496.46 M | 2,480 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aarti Industries
Complete news archive for Aarti Industries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aarti Industries
Aarti Industries was founded in 1984 and raised its 1st funding round 35 years after it was founded.
Aarti Industries is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Suyog Kotecha is the CEO of Aarti Industries, as recorded in our data.
Aarti Industries has 13,910 employees.
The primary company behind Aarti Industries, Aarti Industries Ltd, reported revenue of βΉ8,319 Cr for FY 2026, up 14% year on year.
Founded in 1984 and based in Mumbai, India, operations are centered on the production of specialty chemicals, pharmaceutical intermediates, and surfactants. The pharmaceutical division handles API intermediates, custom synthesis, contract research, and facilities for steroids and oncology drugs. Surfactants serve personal care, industrial, agro, and home care sectors. Chemicals produced support APIs, agrochemicals, polymers, additives, pigments, and dyes.
Aarti Industries offers Para Dichloro Benzene, Nitro Benzene, Ortho Nitro Chloro Benzene, 2,4 Dinitro Chloro Benzene, and Hydro Chloric Acid.
Yes, Aarti Industries is publicly traded on NSE under the ticker symbol AARTIIND.
Aarti Industries is associated with 6 legal entities: Aarti Industries Ltd, Gogri Ventures Llp, Rcg Ventures Llp and others.
The legal entities of Aarti Industries currently have 30 directors, including Hetal Gogri Gala, Rashesh Chandrakant Gogri, Chandrakant Vallabhaji Gogri and others.
